ASBrS Input Needed on Revised VTE Prophylaxis Statement

The ASBrS Research Committee has revised and updated the Consensus Statement on Venous Thromboembolism (VTE) Prophylaxis for Patients Undergoing Breast Operations. ASBrS has revised its process, and moving forward, ASBrS will post drafts of consensus statements, resource guides, clinical pathways, and other documents for public comment before they are finalized and sent to the Board of Directors for final approval.

To review the revised statement and provide comment, please click here.
All comments must be submitted by December 18, 2023.

The public comment period is an integral part of the development process and is preceded by a series of reviews and revisions and may be followed by a final peer review if the document is submitted to a journal for publication. ASBrS encourages our members and colleagues to comment. Please share this with your colleagues to help produce a more robust public response.

An ASBrS Consensus Statement summarizes the indications and management considerations for a specific therapy or procedure. Consensus Statements reflect what ASBrS considers to be optimal practice, but may require modification based on the clinical circumstance, the physicians’ judgment, the patient’s preference, and the consideration that scientific evidence continues to evolve. This statement is not a systematic review of the literature. The statement was developed with a comprehensive review of the modern literature on this subject. The statement reflects the consensus of a panel of Research Committee members, with the approval of the Board of Directors, and is based on multiple sources from the peer‐reviewed literature.

View News Archive